233 South 10th Street
Suite 1006
Philadelphia, PA 19107
(215) 503-8583
Suite 1006
Philadelphia, PA 19107
(215) 503-8583
Most Recent Peer-reviewed Publications
- Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function
- The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
- Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene
- Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68
- Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis
- Cyclin D1 splice variants: Polymorphism, risk, and isoform-specific regulation in prostate cancer
- Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome
- The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer
- Targeting the BAF57 SWI/SNF subunit in prostate cancer: A novel platform to control androgen receptor activity
- Cyclin D3 action in androgen receptor regulation and prostate cancer
- Unique bisphenol A transcriptome in prostate cancer: Novel effects on ERĪ² expression that correspond to androgen receptor mutation status
- Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells
- The complex role of AR signaling after cytotoxic insult: Implications for cell cycle based chemotherapeutics
- Impact of differential cyclin D1 expression and localisation in prostate cancer
- Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer
- LS14: A novel human adipocyte cell line that produces prolactin